Preliminary observations on short-course chemotherapy in tuberculous serositis.
Respiration
; 46(1): 133-8, 1984.
Article
en En
| MEDLINE
| ID: mdl-6494602
Short-course chemotherapy has not been previously assessed in tuberculous serositis. In this study, 18 patients with tuberculous serositis were studied. 600 mg of rifampicin, 300 mg of isoniazid and 25 mg of pyridoxine were given daily for 6 months. 14 patients completed the therapeutic regimen and were evaluated. 11 of these showed excellent results on the long-term follow-up (18-24 months) and 3 of shorter-term follow-up (9-12 months). Short-course chemotherapy appears to be efficacious in the treatment of tuberculous serositis. However, further and larger trials are recommended.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Piridoxamina
/
Rifampin
/
Serositis
/
Tuberculosis
/
Isoniazida
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Respiration
Año:
1984
Tipo del documento:
Article
Pais de publicación:
Suiza